Hormone therapy (HRT), once a common treatment for menopause, faces scrutiny after studies revealed health risks. Is HRT right for you? Let’s explore.
Hormone therapy, often referred to as HRT, is a medical treatment designed to replenish female hormones in the body. It’s primarily used to counteract the decrease in estrogen levels that occurs during menopause. As estrogen production declines, many women experience uncomfortable menopausal symptoms, and HRT is frequently prescribed to alleviate these issues, most notably hot flashes and vaginal discomfort.
Beyond symptom relief, hormone therapy has demonstrated effectiveness in preventing bone density loss and reducing the risk of fractures in postmenopausal women. This added benefit made HRT a popular choice for long-term health management for many years.
However, the landscape of hormone therapy shifted as research uncovered potential risks. These risks are not uniform and depend on several factors: the specific type of hormone therapy used, the dosage, the duration of treatment, and an individual’s pre-existing health conditions. To maximize benefits and minimize risks, hormone therapy should be personalized to each woman’s needs and regularly re-evaluated to ensure the advantages continue to outweigh any potential downsides.
Understanding the Types of Hormone Therapy
Hormone therapy fundamentally aims to replace estrogen, the primary hormone that diminishes after menopause. There are two primary categories of estrogen therapy:
-
Systemic Hormone Therapy: This type of estrogen therapy delivers a higher dose of estrogen that is absorbed throughout the body. It is available in various forms including pills, skin patches, vaginal rings, gels, creams, and sprays. Systemic HRT is capable of addressing a wide range of menopausal symptoms that affect the entire body.
-
Low-Dose Vaginal Products: These products, available as creams, tablets, or vaginal rings, deliver a much lower dose of estrogen directly to the vaginal area. This localized approach minimizes estrogen absorption into the bloodstream, making it primarily suitable for treating vaginal and urinary symptoms of menopause, such as dryness or discomfort.
It’s crucial to note that for women who have not undergone a hysterectomy (uterus removal), estrogen therapy is typically prescribed in conjunction with progesterone or progestin, a synthetic form of progesterone. Estrogen alone, without the balancing effect of progesterone, can stimulate the uterine lining, increasing the risk of endometrial cancer. If a woman has had her uterus removed, progesterone is generally not necessary.
What Are the Potential Risks Associated with HRT?
The most extensive clinical trial on hormone therapy, investigating a combination estrogen-progestin pill (Prempro), revealed an increased risk of certain serious health conditions:
- Cardiovascular Disease: Increased risk of heart disease.
- Stroke: Elevated risk of stroke.
- Blood Clots: Higher likelihood of developing blood clots.
- Breast Cancer: Increased risk of breast cancer.
Further research has refined our understanding of these risks, indicating that they can fluctuate based on several key factors:
- Age Factor: Women who initiate hormone therapy at age 60 or older, or more than a decade after menopause onset, face a greater risk of the conditions listed above. Conversely, for women starting HRT before age 60 or within 10 years of menopause, the benefits appear to be more likely to outweigh the risks.
- Type of Hormone Therapy Matters: The risk profile of hormone therapy is influenced by whether estrogen is administered alone or combined with progestin, as well as the specific type and dosage of estrogen used.
- Individual Health History: A woman’s personal and family medical history, including cancer risk factors, heart disease, stroke, blood clots, liver conditions, and osteoporosis, are critical determinants in evaluating the suitability of hormone therapy.
A comprehensive discussion of these risks between a woman and her doctor is essential when considering hormone therapy as a treatment option.
Who Can Benefit Most from Hormone Therapy?
For healthy women experiencing significant menopausal symptoms, the benefits of hormone therapy may outweigh the risks. HRT may be particularly beneficial for those who:
- Suffer from Moderate to Severe Hot Flashes: Systemic estrogen therapy remains the gold standard and most effective treatment for alleviating troublesome hot flashes and night sweats associated with menopause.
- Experience Other Menopausal Symptoms: Estrogen can effectively address vaginal symptoms like dryness, itching, burning, and pain during sexual intercourse, significantly improving quality of life.
- Require Prevention of Bone Loss and Fractures: Systemic estrogen aids in protecting against osteoporosis, a condition characterized by thinning bones. While bisphosphonates are typically the first-line medications for osteoporosis, estrogen therapy can be a viable alternative for women who cannot tolerate or do not benefit from other treatments.
- Are Experiencing Early Menopause or Estrogen Deficiency: Women who undergo surgical removal of ovaries before age 45, experience premature menopause (periods ceasing before age 45), or have primary ovarian insufficiency (loss of normal ovarian function before age 40) have lower lifetime estrogen exposure compared to women with typical menopause. Estrogen therapy in these cases can mitigate the risk of various health issues linked to estrogen deficiency, including osteoporosis, heart disease, stroke, dementia, and mood changes.
Strategies to Minimize Risks if You Choose HRT
If you and your doctor decide hormone therapy is appropriate, several strategies can help minimize potential risks:
- Personalize Product and Delivery Method: Estrogen is available in various forms, including pills, patches, gels, vaginal creams, and slow-release vaginal suppositories or rings. For women primarily experiencing vaginal symptoms, low-dose vaginal estrogen products are often preferable to systemic options like pills or patches.
- Utilize the Lowest Effective Dose: Employ the lowest dose of hormone therapy necessary to effectively manage symptoms and for the shortest duration required. Women under 45 need sufficient estrogen to protect against the long-term effects of estrogen deficiency. However, for persistent menopausal symptoms that significantly impact quality of life, longer-term treatment may be recommended by a doctor.
- Regular Follow-Up Care is Key: Consistent medical check-ups are crucial to ensure that the benefits of hormone therapy continue to outweigh the risks. Regular screenings such as mammograms and pelvic exams are also essential.
- Adopt Healthy Lifestyle Habits: Incorporate regular physical activity and exercise, maintain a balanced and healthy diet, maintain a healthy weight, abstain from smoking, limit alcohol consumption, manage stress effectively, and manage any existing chronic health conditions like high cholesterol or hypertension.
For women using systemic estrogen therapy who have not had a hysterectomy, progestin is also necessary. Your doctor can guide you in selecting the delivery method that offers the optimal balance of benefits, convenience, and minimal risks and costs.
Alternatives to Hormone Therapy
If hormone therapy is not a suitable option, various strategies can help manage menopausal symptoms. Lifestyle adjustments such as staying cool, reducing caffeine and alcohol intake, and practicing relaxation techniques like paced breathing can help manage hot flashes. Non-hormonal prescription medications are also available to alleviate hot flashes.
For vaginal dryness or painful intercourse, over-the-counter vaginal moisturizers or lubricants can provide relief. Additionally, prescription medications like ospemifene (Osphena) can be considered to address painful intercourse.
The Takeaway: HRT is a Nuanced Choice
Hormone therapy is not inherently good or bad. Determining whether it is the right treatment option for you requires a thorough discussion with your doctor, considering your individual symptoms, health history, and risk factors. It’s vital to maintain this dialogue with your healthcare provider throughout your menopausal journey.
As research continues to evolve our understanding of hormone therapy and other menopause treatments, recommendations may change. Regularly revisiting your treatment options with your doctor ensures you receive the most current and appropriate care for managing bothersome menopausal symptoms.
Women’s health topics – straight to your inbox
Get the latest information from our Mayo Clinic experts on women’s health topics, serious and complex conditions, wellness and more. Click to view a preview and subscribe below.
ErrorEmail field is required
ErrorInclude a valid email address
To provide you with the most relevant and helpful information, and understand which information is beneficial, we may combine your email and website usage information with other information we have about you. If you are a Mayo Clinic patient, this could include protected health information. If we combine this information with your protected health information, we will treat all of that information as protected health information and will only use or disclose that information as set forth in our notice of privacy practices. You may opt out of email communications at any time by clicking on the unsubscribe link in the email.
Thank you for subscribing!
You’ll soon start receiving the latest Mayo Clinic health information you requested in your inbox.
Sorry something went wrong with your subscription
Please, try again in a couple of minutes
Dec. 06, 20221. AskMayoExpert. Menopausal hormone therapy (adult). Mayo Clinic; 2019.
2. Martin KA, et al. Treatment of menopausal symptoms with hormone therapy. https://www.uptodate.com/contents/search. Accessed March 25, 2020.
3. Martin KA, et al. Menopausal hormone therapy: Benefits and risks. https://www.uptodate.com/contents/search. Accessed March 25, 2020.
4. American College of Obstetricians and Gynecologists. Practice Bulletin No. 141: Management of menopausal symptoms. Obstetrics & Gynecology. 2014; doi:10.1097/01.AOG.0000441353.20693.78. Reaffirmed 2018.
5. North American Menopause Society. The 2017 hormone therapy position statement of The North American Menopause Society. Menopause. 2017; doi:10.1097/GME.0000000000000921.
6. North American Menopause Society. Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society. Menopause. 2015; doi:10.1097/GME.0000000000000546.
